PSTX
Poseida Therapeutics, Inc. Common Stock
PSTX
PSTX
Delisted
PSTX was delisted on the 7th of January, 2025.
64 hedge funds and large institutions have $107M invested in Poseida Therapeutics, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 16 increasing their positions, 21 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
Holders
64
Holding in Top 10
1
Calls
$54K
Puts
–
Top Buyers
| 1 | +$692K | |
| 2 | +$262K | |
| 3 | +$259K | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$213K |
| 5 |
DU
Delphia (USA)
Toronto,
Ontario, Canada
|
+$184K |
Top Sellers
| 1 | -$11.6M | |
| 2 | -$1.42M | |
| 3 | -$612K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$577K |
| 5 |
BlackRock
New York
|
-$379K |